Trump met with Amazon’s Jeff Bezos at the White House last week, sources say
Jeff Bezos, founder and executive chairman of Amazon, takes the stage during The New York Times' annual DealBook Summit, at ...
Tag: Bill Gates
Bill Gates says Trump’s cuts to USAID are devastating: ‘It’s not too late to reverse them’
Bill Gates speaks with Reuters during an interview in New York City, U.S., May 8, 2025. Mike Segar | ReutersBill ...
Neuralink competitor Paradromics completes first human implant
Dr. Matthew Willsey working in the operating room.Courtesy of the University of MichiganNeurotech startup Paradromics on Monday announced it has ...
T. Rowe Price sees this established strategy as way to ride out market volatility
It appears T. Rowe Price is benefiting from the record growth in actively managed exchange-traded funds.Tim Coyne, the firm's head ...
Brain implant cleared by FDA for Precision Neuroscience, a Musk Neuralink rival
Precision Neuroscience's Layer 7 Cortical InterfaceCourtesy of Precision NeuroscienceNeurotech startup Precision Neuroscience on Thursday announced that a core component of ...
How the U.S. is losing ground to China in nuclear fusion, as AI power needs surge
China and the U.S. are in a race to create the first grid-scale nuclear fusion energy. After decades of U.S. ...
Bitcoin miners at Donald Trump’s closed-door event say he thinks bitcoin can help win AI arms race
Former U.S. President Donald Trump speaks at a dinner at Mar-a-Lago on June 5, 2024 in West Palm Beach, Florida. ...
Sam Altman takes nuclear energy company Oklo public to help further his AI ambitions
Sam Altman is now chairman of a public company. But it's not OpenAI.On Friday, advanced nuclear fission company Oklo started ...
Meta’s Zuckerberg sees $28 billion windfall after shares rocket
Facebook CEO Mark Zuckerberg is seen after fencing in the "Metaverse" with an Olympic gold medal fencer during a live-streamed ...
Neuralink competitor Synchron to ramp up brain implant production with equity stake in manufacturer
Philip O'Keefe, one of Synchron's patients in the SWITCH clinical trial, was the first person in the world to tweet ...
